Showing results (2481-2490 of 9,164) with videos related to

Sort By:
Pageof 917
Cancer Medicine|February 26, 2025
Doxorubicin Plus Dacarbazine Versus Doxorubicin Plus Ifosfamide in Combination With Regional Hyperthermia in Patients With Advanced Leiomyosarcoma: A Propensity Score-Matched AnalysisLuc M Berclaz, Vindi Jurinovic, Anton Burkhard-Meier, et al.
Cancer Medicine|February 19, 2025
Multi-Institutional MR-Derived Radiomics to Predict Post-Exenteration Disease Recurrence in Patients With T4 Rectal CancerNiall J O'Sullivan, Fariba Tohidinezhad, Hugo C Temperley, et al.
Cancer Medicine|February 13, 2025
Molecular Subtyping and Therapeutic Targeting of IFNG-Driven Immunogenic Cell Death in Lung AdenocarcinomaLifeng Li, Yaqi Yang, Mengle Peng, et al.
Cancer Medicine|November 7, 2024
Racial and Ethnic Differences in Liver Transplantation and Post-Liver Transplant Survival Among Patients With Hepatocellular CarcinomaUdhayvir S Grewal, Apoorva K Chandar, Shiva J Gaddam, et al.
Cancer Medicine|November 4, 2024
Evaluation of the Prognostic Value of the Mayo Additive Staging System and Minimal Residual Disease in Newly Diagnosed Multiple Myeloma PatientsYichuan Song, Rui Zhao, Wenxuan Fu, et al.
Cancer Medicine|November 7, 2024
Pan-Cancer Survival Impact of Immune Checkpoint Inhibitors in a National Healthcare SystemSean R Miller, Matthew Schipper, Lars G Fritsche, et al.
Cancer Medicine|November 6, 2024
The Use of CellCollector Assay to Detect Free Cancer Cells in the Peritoneal Cavity of Colorectal Cancer Patients: An Experimental StudyYudi Wu, Fangxun He, Liang Liu, et al.
Cancer Medicine|November 6, 2024
Isobutyric Acid Promotes Immune Evasion in Colorectal Cancer via Increased PD-L1 ExpressionQiuhua Lin, Han Wang, Wenbo Chen, et al.
Cancer Medicine|November 6, 2024
Improved Therapeutic Efficacy of Doxorubicin Chemotherapy With Cannabidiol in 4T1 Mice Breast Cancer ModelKoorosh Tabatabaei, Sara Moazzezi, Mohammadreza Emamgholizadeh, et al.
Cancer Medicine|November 6, 2024
Combined inhibition of histone methyltransferases EZH2 and DOT1L is an effective therapy for neuroblastomaJanith A Seneviratne, Daenikka Ravindrarajah, Daniel R Carter, et al.
Pageof 917